MA MB BChir MSc DPhil FRCS (Urol) PGDipLATHE
GMC number: 4583888
Year of qualification: 1999
Areas of expertise:
General Urology, Urinary Stone Disease, Benign Prostate Surgery (Urolift, Rezum, TURP).
- Monday afternoon / evening – Manor Hospital, Oxford by arrangement
- Friday afternoon – Manor Hospital, Oxford by arrangement
- Royal College of Surgeons of England (Fellow)
- British Association of Urological Surgeons
- BAUS Section of Endourology
Subspecialty services that this consultant provides:
In addition to general urology Prof Turney specialises in:-
- Diagnosis and treatment of urinary stone disease
- Management of benign prostate disease
Ben Turney is an Associate Professor in Urology in the Nuffield Department of Surgical Sciences and Consultant Urological Surgeon. Ben was an undergraduate at Downing College, Cambridge and undertook surgical training in the Oxford region. He has completed research for both an MSc and DPhil (= PhD) in Oxford. He also obtained a diploma in university level teaching in 2006 from the University of Oxford. As the clinical lead for kidney stone services in Oxford, Ben has driven successful business plans to introduce a fixed site lithotripter in Oxford (2009) and a 100W laser (2012) for stone surgery and laser prostate surgery (HOLEP). Ben hosts the international EBU fellowship in stone management in Oxford – one of only 2 such recognised fellowship programmes in Europe. Ben has benefited from international experience with recognised leaders in the field including Prof Glenn Preminger at Duke University, North Carolina, USA and Prof Olivier Traxer, Hôpital Tenon, Paris. In 2013, Ben was awarded the International Guest Scholarship of the American College of Surgeons, one of only 13 awarded internationally.
Prof Turney’s main research interest is in kidney stone disease. Ben established and leads the Oxford Stone Group and he has active collaborations with proteomics, genetics, biomedical engineering, mathematics, public health and epidemiology departments in Oxford. To support this research Ben has established a biobank of over 800 stone patients using funds obtained from the Oxford Biomedical Research Centre.
More recently, Ben has become involved with a collaboration with McLaren Applied Technologies, part of the McLaren F1 group, to develop new technology in healthcare. This includes activity monitoring to assess patient fitness and new electronic patient pathways.
Work from his research is presented regularly international meetings and published in peer reviewed journals. He has given invited presentations at national and international meetings.
Consultant Urological Surgeon, Oxford University Hospitals Foundation NHS Trust
Associate Professor in Urology, Nuffield Department of Surgical Sciences, University of Oxford.